Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer's disease in two independent European samples

Journal of Alzheimer's Disease

Volumn 16, Issue 1, 2009, Pages 181-187

  Serretti, Alessandro ^a   Olgiati, Paolo ^a   Politis, Antonis ^b   Malitas, Petros ^c   Albani, Diego ^d   Dusi, Sabrina ^d   Polito, Letizia ^d   De Mauro, Stefania ^d   Zisaki, Aikaterini ^e   Piperi, Christina ^e   Liappas, Ioannis ^c   Stamouli, Evangelia ^b   Mailis, Antonis ^b   Atti, Anna Rita ^a   Morri, Monica ^a   Ujkaj, Manjola ^a   Batelli, Sara ^d   Forloni, Gianluigi ^d   Soldatos, Costantine R ^b   Papadimitriou, George N ^b   De Ronchi, Diana ^a   Kalofoutis, Anastasios ^c,e   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c European Centre for the Quality of Life ECQuaL   (Greece)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Alzheimer's disease; IL 1A gene; Inflammatory cytokines; Psychosis

Indexed keywords

INTERLEUKIN 1ALPHA;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE DURATION; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE DOSAGE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GREECE; HETEROZYGOTE; HUMAN; HYPOTHESIS; ITALY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 58849162678     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-0946     Document Type: Article

References (54)

1. Ritchie K, Lovestone S (2002) The dementias. Lancet 360, 1759-1766.
2. Tandon A, Rogaeva E, Mullan M, St George-Hyslop PH (2000) Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins. Curr Opin Neurol 13, 377-384.
3. Gandy S (2005) The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 115, 1121-1129.
4. Mrak RE, Griffin WS (2001) Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 22, 903-908.
5. Sheng JG, Zhu SG, Jones RA, Griffin WS, Mrak RE (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol 163, 388-391.
6. Griffin WS, Mrak RE (2002) Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 72, 233-238.
7. Nicklin MJH, Barton JL, Nguyen M, FitzGerald MG, Duff GW, Kornman K (2002) A Sequence-Based Map of the Nine Genes of the Human Interleukin-1 Cluster. Genomics 79, 718-725.
8. Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi LM, Biunno I (2002) Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 54, 82-86.
9. Rainero I, Bo M, Ferrero M, Valfre W, Vaula G, Pinessi L (2004) Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis. Neurobiol Aging 25, 1293-1298.
10. Ki CS, Na DL, Kim DK, Kim HJ, Kim JW (2001) Lack of association of the interleukin-1alpha gene polymorphism with Alzheimer's disease in a Korean population. Ann Neurol 49, 817-818.
11. Kuo YM, Liao PC, Lin C, Wu CW, Huang HM, Lin CC, Chuo LJ (2003) Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia. Alzheimer Dis Assoc Disord 17, 94-97.
12. Tsai SJ, Liu HC, Liu TY, Wang KY, Hong CJ (2003) Lack of association between the interleukin-1alpha gene C(-889)T polymorphism and Alzheimer's disease in a Chinese population. Neurosci Lett 343, 93-96.
13. Li XQ, Zhang JW, Zhang ZX, Chen D, Qu QM (2004) Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population. J Neural Transm 111, 1183-1190.
14. Yucesoy B, Peila R, White LR, Wu KM, Johnson VJ, Kashon ML, Luster MI, Launer LJ (2006) Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol Aging 27, 211-217.
15. Politis AM, Mayer LS, Passa M, Maillis A, Lyketsos CG (2004) Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic. Int J Geriatr Psychiatry 19, 203-208.
16. American Psychiatric Association (2002) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Revised, American Psychiatric Association, Washington, DC.
17. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
18. Cummings J, Mega M, Gray K, Rosenberg-Thompson S, Carusi D, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314.
19. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA (1988) Cornell Scale for Depression in Dementia. Biol Psychiatry 23, 271-284.
20. Politis A, Maillis A, Thomadaki O, Passa M, Stamouli E, Kotrotsou M, Kontoaggellos K, C S (2006) Validity and reliability of the newly translated Cornell Scale for Depression in Dementia (CSDD) applied to Greek outpatients with depression and depression and Alzheimer's disease. Ann Gen Psychiatry 5, S245.
21. World Health Organization (1990) Composite International Diagnostic Interview.
22. De Ronchi D, Berardi D, Menchetti M, Ferrari G, Serretti A, Dalmonte E, Fratiglioni L (2005) Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord 19, 97-105.
23. De Ronchi D, Bellini F, Berardi D, Serretti A, Ferrari B, Dalmonte E (2005) Cognitive Status, Depressive Symptoms, and Health Status as Predictors of Functional Disability Among Elderly Persons With Low-to-Moderate Education: The Faenza Community Aging Study. Am J Geriatr Psychiatry 13, 672-685.
24. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139, 1136-1139.
25. Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, Binetti G, Bonvicini C, Squitti R, Palermo MT, Davis DG, Antuono P, Wekstein DR, Dobrina A, Gennarelli M, Fazio VM (2005) Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 26, 455-464.
26. Armitage P (1955) Tests for linear trends in proportions and frequencies. Biometrics 11, 375-386.
27. Cohen J (1988) Statistical power analysis for the behavioral sciences, Lawrence Erlbaum Associates, Hillsdale, New Jersey.
28. Erdfelder E, Faul F, Buchner A (1996) GPOWER: A general power analysis program. Behav Res Methods Instrum Comput 28, 1-11.
29. Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G, Sorbi S, Mariani C, Canal N, Griffin WS, Franceschi M (2000) Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 47, 361-365.
30. Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmuller F, Muller U, Kurz A, Zimmer R, Evans RM, Hake A, Gasser T, Oertel WH, Griffin WS, Paul SM, Farlow MR (2000) Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 55, 480-483.
31. Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47, 365-368.
32. Rebeck GW (2000) Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci Lett 293, 75-77.
33. Murphy GM, Jr., Claassen JD, DeVoss JJ, Pascoe N, Taylor J, Tinklenberg JR, Yesavage JA (2001) Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele. Neurology 56, 1595-1597.
34. Kolsch H, Ptok U, Bagli M, Papassotiropoulos A, Schmitz S, Barkow K, Kockler M, Rao ML, Maier W, Heun R (2001) Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease. Ann Neurol 49, 818-819.
35. Hedley R, Hallmayer J, Groth DM, Brooks WS, Gandy SE, Martins RN (2002) Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann Neurol 51, 795-797.
36. Combarros O, Sanchez-Guerra M, Infante J, Llorca J, Berciano J (2002) Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease. J Neurol 249, 1242-1245.
37. Pirskanen M, Hiltunen M, Mannermaa A, Iivonen S, Helisalmi S, Lehtovirta M, Koivisto AM, Laakso M, Soininen H, Alafuzoff I (2002) Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease. Dement Geriatr Cogn Disord 14, 123-127.
38. Bosco P, Gueant-Rodriguez RM, Anello G, Romano A, Namour B, Spada RS, Caraci F, Tringali G, Ferri R, Gueant JL (2004) Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 75, 1036-1038.
39. Tang MN, Zhang ZX, Han HY, Liu XH, Shen Y (2004) [Analysis on association between the polymorphisms in apolipoprotein E, interleukin-1 alpha genes and Alzheimer's disease in Chengdu area]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21, 176-178.
40. Jhoo JH, Park WY, Kim KW, Lee KH, Lee DY, Youn JC, Suh YJ, Seo JS, Woo JI (2004) No evidence of association of interleukin-1 A (-889) genetic polymorphism with Alzheimer's disease in Koreans. Genomics Informatics 2, 81-85.
41. Fidani L, Goulas A, Mirtsou V, Petersen RC, Tangalos E, Crook R, Hardy J (2002) Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease. Neurosci Lett 323, 81-83.
42. Clarimon J, Bertranpetit J, Calafell F, Boada M, Tarraga L, Comas D (2003) Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population. Psychiatr Genet 13, 85-90.
43. Kraft JB, Slager SL, McGrath PJ, Hamilton SP (2005) Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 58, 374-381.
44. Quaranta D, Bizzarro A, Marra C, Vita MG, Seripa D, Pilotto A, Sebastiani V, Mecocci P, Masullo C (2009) Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association. J Alzheimers Dis 16, 173-180.
45. Serretti A, Olgiati P, De Ronchi D (2007) Genetics of Alzheimer's Disease. A Rapidly Evolving Field. J Alzheimers Dis 12, 73-92.
46. Kendler KS (2005) "A gene for...": the nature of gene action in psychiatric disorders. Am J Psychiatry 162, 1243-1252.
47. Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 29, 891-909.
48. Anisman H, Ravindran AV, Griffiths J, Merali Z (1999) Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4, 182-188.
49. Anisman H, Kokkinidis L, Merali Z (2002) Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav Immun 16, 544-556.
50. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ (2003) Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 28, 1182-1185.
51. Fertuzinhos S, Oliveira J, Nishimura A, Pontual D, Carvalho D, Sougey E, Otto P, Zatz M (2004) Analysis of IL-1alpha, IL-1beta, and IL-1RA [correction of IL-RA] polymorphisms in dysthymia. J Mol Neurosci 22, 251-256.
52. Rosa A, Peralta V, Papiol S, Cuesta M, Serrano F, Martinez-Larrea A, L. F (2004) Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 124, 10-14.
53. McCulley MC, Day IN, Holmes C (2004) Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 124, 50-53.
54. Pritchard JK, Rosenberg NA (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am J Human Genet 65, 220-228.